Details of the Drug Combinations

General Information of This Drug (ID: DMJO6GV)

Drug Name

Abciximab DMJO6GV

Synonyms

ReoPro (TN)

Indication

Disease Entry	ICD 11	Status	REF
Acute disease	N.A.	Approved	[1]
Angina pectoris	BA40	Approved	[2]
Brain ischaemia	8B1Z	Approved	[3]
------------------------------------------------------------------------------------

Therapeutic Class

Anticoagulants

Drug Type

Monoclonal antibody

List of Combinatorial Drugs (CBD) Containing This Drug

1 Clinical Trial Drug Combination(s) Consisting of This drug

DrugCom Name	DrugCom ID	Component Drug	Indication	REF
Heparin + Abciximab	DC1HU8S	Heparin	Angioplasty, Transluminal, Percutaneous Coronary	[4]
------------------------------------------------------------------------------------

References

1	Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Circulation. 2004 Oct 26;110(17):2747-71.
2	URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 6584).
3	Emergent carotid stenting and intra-arterial abciximab in acute ischemic stroke due to tandem occlusion. Br J Neurosurg. 2017 Oct;31(5):573-579.
4	ClinicalTrials.gov (NCT00269880) A Study Comparing the Efficacy and Safety of Abciximab, an Anti-Platelet Therapy, in Combination With Two Different Heparin Regimens in Patients Undergoing Percutaneous Coronary Intervention.